Introduction 4 6
Amino acids (AAs) are critical to skeletal muscle plasticity, acting as both substrates in the 4 7 process of muscle protein synthesis (MPS) as well as initiating the signaling pathways which 4 8 activate this cellular process (32, 33) . Carbohydrate (CHO) ingestion can also elevate MPS via 4 9 1 0 2 an initial baseline blood sample was obtained from all participants. A skeletal muscle biopsy 1 0 3 sample was then taken from the vastus lateralis of a randomised leg using the Bergstrom 1 0 4 percutaneous needle technique, modified for suction (30) . Participants then consumed a 1 0 5 commercially available protein-carbohydrate beverage (Gatorade Recover®, Gatorade, Chicago, 1 0 6 IL, USA.) providing 20/44/1g of protein, carbohydrate and fat respectively. Further venous blood 1 0 7 samples were taken every 20 minutes for a 3h post-prandial period and subsequent skeletal 1 0 8 muscle biopsy samples were obtained at 1h and 3h following beverage ingestion. Muscle samples were blotted free of excess blood and dissected free of any excess adipose and 1 1 0 connective tissue, then immediately frozen in liquid nitrogen and stored at -80ºC until analysis. A separate piece of muscle tissue was placed in optimal cutting temperature (OCT) compound 1 1 2 (VWR, Lutterworth, UK.) and frozen in liquid nitrogen-cooled isopentane before storage at -1 1 3 80ºC. Blood samples were collected into EDTA-coated vacutainers (BD, Franklin Lakes, NJ, 1 1 4 USA.) and then centrifuged at 1000g for 15min to separate plasma. Plasma was then aliquotted 1 1 5 into micro-centrifuge tubes and stored at -80ºC until analysis. The experimental design is 1 1 6 depicted in Figure 1 . Plasma insulin concentrations were quantified using a commercially-available ELISA kit (IBL 1 1 9
International, Hamburg, Germany.) as per the manufacturer's instructions. Plasma leucine 1 2 0 concentrations were determined via gas chromatography-mass spectrometry (GC-MS) using an 1 2 1 internal standard method, as previously described (19), following the conversion of plasma free 1 2 2 amino acids to their N-tert-butyldimethyl-silyl-N-methyltrifluoracetamide (MTBSTFA) S6K1 and AKT kinase activity assays were conducted as described previously (18) AKT (DSTT, Dundee, UK). Briefly, a ~30mg piece of muscle tissue was homogenized on ice in 1 2 8 RIPA buffer (50 mmol/l Tris·HCl pH 7.5, 50 mmol/l NaF, 500 mmol/l NaCl, 1 mmol/l sodium 1 2 9 vanadate, 1 mmol/l EDTA, 1% (vol/vol) Triton X-100, 5 mmol/l sodium pyrophosphate, 0.27 1 3 0 mmol/l sucrose, and 0.1% (vol/vol) 2-mercaptoethanol and Complete protease inhibitor cocktail 1 3 1 (Roche)). Cellular debris was then removed via centrifugation at 13000g for 15min (4ºC). and once in assay buffer (50 mM Tris·HCl pH 7.4, 0.03% Brij35, and 0.1% -mercaptoethanol). Immunoprecipitates were then resuspended in 10µL assay buffer and activity assay commenced Vps34 kinase activity assays were conducted as previously described (17) onto an aluminium-backed 60 A silica ˚ TLC plate (Merck, Damstadt, Germany). This was then 1 6 3 run in a TLC chamber solvent system to determine 32γP transfer to substrate. Immunohistochemical analysis was conducted as described previously (28). In short, 5µm Instrument Company Ltd., Huntingdon, UK) and transferred to room temperature (RT) glass primary antibodies (antibodies and dilutions in Table 1 ) diluted in 5%NGS to prevent non-1 7 3 specific secondary binding for 2h at RT. Subsequently, sections were again washed in PBS and 1 7 4 then incubated in corresponding secondary antibodies (details in Table 1 ) for 1h at RT. Following further washes, slides were then incubated in Wheat Germ Agglutinin (WGA -1 7 6 conjugated to 350nm fluorophore) for 30min at RT in order to mark the sarcolemmal membrane. After a final wash in PBS, slides were then mounted in Mowiol® 4-88 (Sigma-Aldrich, Poole, 1 7 8 UK) to protect fluorophores and a glass coverslip was applied. Slides were then left to dry 1 7 9 overnight in a dark cabinet prior to image capture. Pilot stains were also conducted with and 1 8 0 without the presence of the Vps34 primary antibody to ensure no non-specific binding of the In the current study, DAPI UV (340-380nm) excitation filter was utilized to visualize WGA, TxRed (540-580nm) for mTOR visualization and FITC (465-495nm) for LAMP2.Vps34 Pearson's correlation coefficient (Image-Pro software) was used to quantify co-localization of 1 9 5 proteins stained in different channels. This method of assessing co-localization was utilized as it 1 9 6 measures co-localization on a pixel-by-pixel basis and is relatively free of user bias (7). In vitro experiments 1 9 8 C2C12 myoblasts were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA.) and cultured on 150mm culture plates in high glucose Dulbecco's minimum essential (PS, ThermoFisher Scientific). When 80% confluent, cells were trypsinized (0.05% Trypsin-2 0 3 EDTA, ThermoFisher Scientific) and seeded onto 6-well plates at a density of 2x10 5 cells/well. Myoblasts were then cultured until ~95% confluency (~36h) at which time media was changed 2 0 5 to elicit differentiation of myoblasts to myotubes (DMEM supplemented with 2% horse serum 2 0 6 (HS, Hyclone, VWR) and 1% PS). Differentiation was allowed to occur for 5 days, with media 2 0 7 replaced every other day, until myotubes were fully formed. ThermoFisher Scientific) for ~14h, with a subset of myotubes maintained in DMEM (2%HS, 2 1 0 1%PS) to serve as a 'baseline' condition. Following nutrient deprivation, a subset of myotubes 2 1 1 were collected and the remaining myotubes were split into 2 conditions, serum recovery and at -80ºC until analysis. Experiments were conducted in triplicate at 3 separate passage numbers Human primary myoblasts were isolated from 4 patients (age 61±6yrs, BMI 28.7±0.65kg/m 2 , 2 2 5 mean±SEM) as previously described (23). Cells were passaged at 60% confluency on 0.2% 2 2 6 gelatin-coated 100mm culture plates in Hams F10 media (ThermoFisher Scientific, 2 2 7 supplemented with 20% FBS and 1% PS) to prevent spontaneous fusion of myoblasts to 2 2 8 myotubes, and at passage 3 were seeded onto 6-well plates at a density of 5x10 4 cells/well. Myoblasts were then cultured to 80-90% confluency, at which time media was changed to induce 2 3 0 differentiation to myotubes (F10 supplemented with 6% HS and 1% PS). Once myotubes were 2 3 1 fully formed (6-10days), experiments were conducted in a similar fashion to those described for myotubes isolated from each patient and the mean of these results utilized for statistical 2 3 8 analysis.
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Cell lysates were subsequently homogenised by sonication (3x15s at 50% maximal wattage) and 2 4 0 centrifuged at 8000g for 10mins at 40ºC to remove insoluble material. Protein content of these 2 4 1 lysates was then determined by DC protein assay (BioRad, Hercules, CA, USA.) and samples 2 4 2 were diluted to a desired protein concentration in 1x Laemmli sample buffer and boiled at 95ºC 2 4 3 for 5 minutes to denature proteins. Immunoblotting analysis was conducted as described previously (29) USA.) and stained with Ponceau S as a loading control. Membranes were then blocked in 3% 2 4 9 skimmed-milk diluted in Tris-buffered Saline with tween (TBST) for 1h at RT. Following relation to its total protein content, after each target had been normalized to a loaded control 2 5 6 (Ponceau). All primary antibodies utilized for immunoblotting were purchased from CST and 2 5 7 diluted at 1:1000 in TBST unless stated otherwise: p70 ribosomal S6 kinase 1 (S6K1, #2708), p- within-subject factor (condition). A one-way ANOVA with one between-subject factor 2 6 7 (condition) was used to analyse changes in phosphorylation status of proteins in C2C12 Mauchly's test of sphericity. If a significant main effect was found, post-hoc analysis was 2 7 0 conducted on comparisons determined a priori with the Holm-Bonferroni correction for multiple 2 7 1 comparisons. Significance for all variables was set at p<0.05 and data are presented as 2 7 2 mean±SEM unless otherwise stated. For plasma insulin analysis, physiological results from 7 out of 8 participants were obtained and, changes in plasma insulin concentrations (p<0.001), however, following post hoc analysis no 2 7 8 differences between individual time points were noted (p>0.05, Figure 2A ). A significant time 2 7 9 effect was also observed for plasma leucine concentrations (p<0.001). Plasma leucine 2 8 0 concentrations were elevated above basal levels at 20min post-feeding (0.113±0.006 vs. of PRE, 3h -149.6±23.2% of PRE, p=0.003 & p=0.004 respectively, Figure 2C ). Activity of 2 8 7 S6K1 also trended toward being greater at 3h post-feeding compared to PRE (p=0.07, Figure   2 8 8 2C). A significant time effect was also apparent for AKT activity (p=0.05, Figure 2D ). Following 2 8 9 post hoc analysis, however, no differences in AKT activity between individual time points was 2 9 0 apparent (1h -206.9±46.6% of PRE, 3h -118.1±15.5% of PRE, p>0.05, Figure 2D ). Finally, no 2 9 1 differences in Vps34 activity were noted at any time point (p>0.05, Figure 2E ). No time effect for mTOR co-localization with LAMP2 (lysosomal marker) was found (p=0.347, 2 9 4 Figure 3B ) suggesting these proteins are co-localized independently of a nutritional stimulus. A 2 9 5 significant time effect was observed for mTOR co-localization with WGA (membrane marker, 2 9 6 p=0.026). Following feeding, mTOR-WGA co-localization increased by 17% at 1h before 2 9 7 returning to basal values by 3h, however, following post hoc analysis, no alterations were vs. 3h p=0.067, Figure 3C ). Vps34 co-localization with WGA exhibited a trend toward a time toward a greater mTOR-Vps34 co-localization 1h post-feeding compared to 3h was noted 3 0 6 (0.347±0.024 vs. 0.315±0.016, p=0.067, Figure 4C ). In C2C12 myotubes, a significant effect of treatment was found for S6K1 Thr389 phosphorylation 3 0 9 (p<0.001, Figure 5A ). Here, nutrient/serum withdrawal significantly attenuated S6K1 Thr389 3 1 0 phosphorylation compared to baseline levels (34% reduction, p<0.001), whereas phosphorylation 3 1 1 was elevated by 65% and 50% in serum recovery (SR) and SR+SAR405 treatments respectively 3 1 2 (both p<0.001, Figure 5A ) with no difference between these two conditions (p=0.26). A 3 1 3 treatment effect was also noted for 4EBP1 Thr37/46 phosphorylation (p<0.001), however subsequent 3 1 4 post hoc analysis revealed nutrient/serum withdrawal only significantly altered phosphorylation 3 1 5 compared to baseline (~28% reduction, p=0.015, Figure 5B ). Again, no difference between SR 3 1 6 and SR+SAR405 was observed (p=0.57).
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A significant treatment effect was also noted for both RPS6 Ser235/236 and RPS6 Ser240/244 3 1 8 phosphorylation (both p<0.001). RPS6 Ser235/236 phosphorylation was significantly reduced by 3 1 9 nutrient/serum withdrawal (33%, p<0.001, Figure 5C ), whereas SR elicited a significant 3 2 0 elevation in RPS6 ser235/236 phosphorylation above baseline levels (32.7% increase, p=0.038, 3 2 1 Figure 5C ). A trend toward SR+SAR405 eliciting an elevation in RPS6 Ser235/236 phosphorylation, 3 2 2 compared to baseline, was also observed (29.5% increase, p=0.05) with no difference between relation to baseline (18% reduction, p<0.001, Figure 5D ). No difference between SR and 3 2 6 SR+SAR405 was observed (p=0.80). Representative immunoblots are displayed in Figure 5E . In human primary myotubes, a significant treatment effect was noted for S6K1 Thr389 3 2 8 phosphorylation (p<0.001). Here, serum/nutrient withdrawal reduced S6K1 Thr389 phosphorylation 3 2 9
by ~70% compared to baseline (p=0.026, Figure 6A ). SR and SR+SAR405 both elevated Figure 6A ). A trend for a greater response in SR, compared to SR+SAR405, was also observed 3 3 2 (p=0.069). A treatment effect for 4EBP1 Thr37/46 phosphorylation was also observed (p=0.004), individual treatment conditions was apparent (p>0.05, Figure 6B ). Significant treatment effects 3 3 5 were also observed for RPS6 Ser235/236 and RPS6 Ser240/244 phosphorylation, however post hoc 3 3 6 analysis for both these variables did not reveal differences between individual treatments The class III PI3Kinase, Vps34, has been proposed as a nutrient/amino acid sensitive regulator of in vitro studies demonstrated that the Vps34 specific inhibitor SAR405 did not affect nutrient The finding that PRO-CHO ingestion did not increase Vps34 kinase activity was contrary to our 3 5 3 hypothesis and contrasts previous studies (4, 22) . Previously, it has been shown that high- reported in the current study, we would expect our feeding protocol to result in similar increases 3 5 8 in intramuscular leucine (1). In human skeletal muscle, there is only one previous study to have 3 5 9 assessed Vps34 kinase activity (26). Here, sprint exercise combined with PRO-CHO ingestion 3 6 0 did not alter kinase activity, whereas exercise in the fasted state elicited a trend toward elevated 3 6 1 activity ~1.5h following the final exercise bout. Importantly, in combination with our findings, 3 6 2 this suggests that Vps34 kinase is not solely activated by leucine in human skeletal muscle and 3 6 3 may suggest that a contraction stimulus is needed to activate this kinase. In an attempt to further clarify the role of Vps34 in mTORC1 activation in skeletal muscle, we 3 6 5 completed in vitro experiments in both C2C12 and human primary myotubes, utilising the Vps34 3 6 6 specific inhibitor SAR405 (25). In support of our findings in vivo, we observed no effect of 3 6 7 SAR405 administration on mTORC1 signaling responses to serum recovery in C2C12 or human 3 6 8 primary myotubes, suggesting Vps34 kinase activity is not necessary for mTORC1 activation. Recent work from our lab (11, 28), and others (15) suggests that mTORC1 activation in skeletal 3 7 0 muscle involves the translocation of mTORC1-lysosome complexes to peripheral regions of the 3 7 1 cell (12). Here, we report a similar process by which mTOR-LAMP2 co-localize in the fasted 3 7 2 state, prior to mTOR-LAMP2 complex translocation post PRO-CHO ingestion. Vps34 has 3 7 3 previously been implicated in mTOR translocation in vitro, where it is required for the 3 7 4 recruitment of mTOR to lamellipodia (cellular projections of motile cells) in response to insulin 3 7 5 stimulation, co-localizing with mTOR in these regions (10). In the current study, we also found 3 7 6
Vps34 translocation toward the cell periphery following nutrient provision, with a trend toward a 3 7 7 time effect noted for Vps34-WGA co-localization (p=0.053). In this context, Vps34-WGA co- 
